Physician profile
Tuna Ozyurekoglu
NPI 1659365930
$24,723.09
in general payments reported to CMS, 2019-2025
15 companies · $18K in 2025
The $18K reported for 2025 was more than what 95% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,945 · 2020: $26.47 · 2021: $1,801 · 2022: $336 · 2023: $84.12 · 2024: $2,990 · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Travel and Lodging: $5,323 · Food and Beverage: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,492.00 |
| Travel and Lodging | $5,322.80 |
| Food and Beverage | $800.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $21,196.51 | 2019-2025 | Variax, Pangea, Pro |
| Ossio INC | $1,524.00 | 2021 | |
| Alpha Orthopedic Systems | $927.18 | 2019 | |
| Endo Pharmaceuticals INC. | $426.36 | 2019-2024 | Xiaflex |
| Checkpoint Surgical, INC | $153.44 | 2022 | |
| Axogen | $91.32 | 2021 | |
| Skeletal Dynamics INC | $78.87 | 2021 | |
| Endo USA, INC. | $70.73 | 2024-2025 | Xiaflex |
| Smith+Nephew, INC. | $64.80 | 2023-2024 | Stravix, Renasys Touch, Pico |
| Integra Lifesciences Corporation | $53.86 | 2020-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Polynovo North America LLC | $41.25 | 2024-2025 | Novosorb Btm |
| Medartis INC. | $35.55 | 2021 | |
| Acumed LLC | $20.67 | 2022 | |
| Bioventus LLC | $19.48 | 2022 | |
| Amgen INC. | $19.07 | 2025 | Evenity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tuna Ozyurekoglu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.